IHS Chemical Week

Chemical Week Magazine :: Newsbriefs

Private Equity Firms Line up for Merck KGaA’s Generics

1:38 PM MDT | January 24, 2007 | Chemical Week Editorial Staff

Private equity capital companies Cinven, Texas Pacific Group, and Permira are among companies that have expressed an interest in acquiring Merck KGaA’s generic drugs business, which is up for sale, according to German press reports last week (CW, Jan. 17, p. 23). Meanwhile, Ranbaxy (Gurgaon, India), India’s biggest manufacturer of pharmaceuticals, says it is considering teaming up with a private equity firm to bid for Merck KGaA’s generics. Pharma manufacturers Actavis (Hafnarfjordur, Iceland) and Sanofi-Aventis may also be interested in buying...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa